Sterling Capital Management’s Tourmaline Bio TRML Stock Holding History

Sterling Capital Management’s Portfolio TRML Stock Details TRML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,208	Closed	-$57.8K	–	3275
2025 Q3	$57.8K	Buy	1,208 +694	+135%	+$19.2K	﹤0.01%	1711
2025 Q2	$8.22K	Buy	514 +116	+29%	+$1.88K	﹤0.01%	2254
2025 Q1	$6.05K	Sell	398 -342	-46%	-$5.48K	﹤0.01%	2063
2024 Q4	$15K	Buy	740 +655	+771%	+$16.5K	﹤0.01%	1978
2024 Q3	$2.19K	Buy	+85	New	+$1.42K	﹤0.01%	2142

Sterling Capital Management's TRML Position: Q4 2025 in Review

Sterling Capital Management sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 1,208 shares — an estimated $57.8K sold.

Sterling Capital Management first reported a position in TRML in Q3 2024 and held it in 5 quarters. The position peaked at $57.8K in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

Sterling Capital Management reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
Sterling Capital Management sold 1,208 Tourmaline Bio shares in Q4 2025, an estimated $57.8K.
Sterling Capital Management first reported a position in Tourmaline Bio in Q3 2024 and held it in 5 quarters.
Sterling Capital Management's Tourmaline Bio position peaked at $57.8K in Q3 2025.
0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on Sterling Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.